Cargando…
A Bivalent Supramolecular GCP Ligand Enables Blocking of the Taspase1/Importin α Interaction
Taspase1 is a unique protease not only pivotal for embryonic development but also implicated in leukemia as well as solid tumors. As such, it is a promising target in cancer therapy, although only a limited number of Taspase1 inhibitors lacking general applicability are currently available. Here we...
Autores principales: | Höing, Alexander, Zimmermann, Alexander, Moews, Lisa, Killa, Matthias, Heimann, Marius, Hensel, Astrid, Voskuhl, Jens, Knauer, Shirley K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298320/ https://www.ncbi.nlm.nih.gov/pubmed/34623765 http://dx.doi.org/10.1002/cmdc.202100640 |
Ejemplares similares
-
The Taspase1/Myosin1f-axis regulates filopodia dynamics
por: Hensel, Astrid, et al.
Publicado: (2022) -
Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription
por: Oelschläger, Lisa, et al.
Publicado: (2023) -
Bioassays to Monitor Taspase1 Function for the Identification of Pharmacogenetic Inhibitors
por: Knauer, Shirley K., et al.
Publicado: (2011) -
Overexpression of the Catalytically Impaired Taspase1(T234V) or Taspase1(D233A) Variants Does Not Have a Dominant Negative Effect in T(4;11) Leukemia Cells
por: Bier, Carolin, et al.
Publicado: (2012) -
Computational model predicts protein binding sites of a luminescent ligand equipped with guanidiniocarbonyl-pyrrole groups
por: Rafieiolhosseini, Neda, et al.
Publicado: (2022)